Ensysce Biosciences (ENSC) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to -$137.0 million.
- Ensysce Biosciences' Retained Earnings fell 870.97% to -$137.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$137.0 million, marking a year-over-year decrease of 870.97%. This contributed to the annual value of -$129.5 million for FY2024, which is 657.08% down from last year.
- As of Q3 2025, Ensysce Biosciences' Retained Earnings stood at -$137.0 million, which was down 870.97% from -$133.2 million recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Retained Earnings registered a high of -$57.8 million during Q2 2021, and its lowest value of -$137.0 million during Q3 2025.
- In the last 5 years, Ensysce Biosciences' Retained Earnings had a median value of -$115.6 million in 2023 and averaged -$109.7 million.
- In the last 5 years, Ensysce Biosciences' Retained Earnings crashed by 161956.16% in 2021 and then crashed by 519.7% in 2025.
- Over the past 5 years, Ensysce Biosciences' Retained Earnings (Quarter) stood at -$85.8 million in 2021, then fell by 29.22% to -$110.9 million in 2022, then dropped by 9.58% to -$121.6 million in 2023, then dropped by 6.57% to -$129.5 million in 2024, then dropped by 5.72% to -$137.0 million in 2025.
- Its last three reported values are -$137.0 million in Q3 2025, -$133.2 million for Q2 2025, and -$131.5 million during Q1 2025.